Two Targets, One Hit: new Anticancer Therapeutics to Prevent Tumorigenesis Without Cardiotoxicity

Szabo, Z; Hornyak, L; Miskei, M; Szekvolgyi, L

Szekvolgyi, L (corresponding author), Univ Debrecen, MTA DE Momentum Genome Architecture & Recombinat, Dept Biochem & Mol Biol, Fac Med,Doctoral Sch Mol Cell & Immune Biol, Debrecen, Hungary.; Szekvolgyi, L (corresponding author), Univ Debrecen, Fac Pharm, Debrecen, Hungary.

FRONTIERS IN PHARMACOLOGY, 2021; 11 ():

Abstract

A serious adverse effect of cancer therapies is cardiovascular toxicity, which significantly limits the widespread use of antineoplastic agents. The p......

Full Text Link